A baby aspirin a day could lower the risk of breast cancer, in addition to supporting heart health.
Millions of people take a low-dose aspirin daily in hopes of reducing their chances of having a heart attack. For women, might aspirin also help prevent breast cancer?
The researchers analyzed data on 57,164 women, most in their early 60s, who had no history of breast cancer. About 23 percent of the women reported taking a low-dose aspirin (81 milligrams), 18 percent took ibuprofen, 11 percent took full-strength aspirin (325 mg) and about 10 percent took a COX-2 inhibitor or another nonsteroidal anti-inflammatory drug (NSAID). All were taking the medication at least three times a week.
Over seven years, 1,457 women got a breast-cancer diagnosis. Those taking low-dose aspirin were 16 percent less likely to have developed any type of breast cancer, compared with women who took no NSAID. They were 20 percent less likely to have developed the most common type: breast cancer that is hormone-receptor-positive and HER2-negative. The study did not find similar links between regular-dose aspirin or other NSAIDs and the risk for breast cancer.
|Read Full Article: For women, baby aspirin may reduce risk of breast cancer – The Washington Post|